Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Eberhard Schatz

Datos Biográficos

ID6779169
NOMBREEberhard Schatz
NOMBRESEberhard
APELLIDOSchatz
FIRMASCHATZ E
ORCID0000-0003-1636-790X
VERIFICADOSí
TOTAL DE OBRAS5
TOTAL DE CITAS0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2017
AÑO MÁS RECIENTE DE PUBLICACIÓN2022
ÍNDICE H0
  • Monitoring progress towards elimination of hepatitis B and C in the EU/EEA

    Open Access•Katherine C Sharrock, Teymur Noori et al.•ARTICLE•PLOS Global Public Health•2022

    This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU/EEA countries along with relevant data from existing sources. Data for 2017 were collected from t…

  • Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe

    Open Access•Perrine Roux, Cécile Donadille et al.•ARTICLE•International Journal of Drug…•2021

  • The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries

    Open Access•Mojca Matičič, Zala Pirnat et al.•ARTICLE•Harm Reduction Journal•2020

    BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy to eliminate HCV as public health threat by 2030. To achieve this, key policies for PWID must be implemented and HCV continuum of care needs to be moni…

  • Nobody Left Outside (NLO) Checklist

    Open Access•Jeffrey V Lazarus, Mario Cascio et al.•ARTICLE•International Journal of…•2019

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)

  • Restrictions on access to direct-acting antivirals for people who inject drugs

    Open Access•Jeffrey V Lazarus, Kelly Safreed-Harmon et al.•ARTICLE•International Journal of Drug…•2017

Sin obras prominentes en esta página.

  • Restrictions on access to direct-acting antivirals for people who inject drugs

    Open Access•Jeffrey V Lazarus, Kelly Safreed-Harmon et al.•ARTICLE•International Journal of Drug…•2017

  • Nobody Left Outside (NLO) Checklist

    Open Access•Jeffrey V Lazarus, Mario Cascio et al.•ARTICLE•International Journal of…•2019

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)

  • The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries

    Open Access•Mojca Matičič, Zala Pirnat et al.•ARTICLE•Harm Reduction Journal•2020

    BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy to eliminate HCV as public health threat by 2030. To achieve this, key policies for PWID must be implemented and HCV continuum of care needs to be moni…

  • Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe

    Open Access•Perrine Roux, Cécile Donadille et al.•ARTICLE•International Journal of Drug…•2021

  • Monitoring progress towards elimination of hepatitis B and C in the EU/EEA

    Open Access•Katherine C Sharrock, Teymur Noori et al.•ARTICLE•PLOS Global Public Health•2022

    This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was developed by the European Centre for Disease Prevention and Control, which combined newly collected data from EU/EEA countries along with relevant data from existing sources. Data for 2017 were collected from t…

Harm reduction (4 obras) · Medicine (4 obras) · Environmental health (3 obras) · Health care (3 obras) · Hepatitis B Virus Studies (3 obras) · Hepatitis C virus research (3 obras) · HIV, Drug Use, Sexual Risk (3 obras) · Political science (3 obras) · Psychology (3 obras) · Business (2 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae